AI-CVD vs Rapid RV/LV
AI Verdict
Choose AI-CVD if…
Choose AI-CVD if your institution aims to proactively identify a broad spectrum of hidden cardiovascular and multisystem disease risks in patients undergoing routine chest and abdominal CT scans. This tool is ideal for opportunistic screening, leveraging existing imaging data without additional radiation or contrast, to detect conditions like coronary artery calcium and cardiac chamber abnormalities early.
View AI-CVD →Choose Rapid RV/LV if…
Choose Rapid RV/LV if your priority is the rapid and accurate assessment of pulmonary embolism severity in patients presenting with suspected PE and undergoing CTPA. This AI tool is specifically designed to quickly calculate the critical right-to-left ventricle ratio, aiding clinicians in urgent triage and treatment decisions for pulmonary embolism cases.
View Rapid RV/LV →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | AI-CVD | Rapid RV/LV |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing information. |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid RV/LVRapid RV/LV emphasizes rapid results within minutes and aims to reduce inter-rater variability, suggesting a streamlined and efficient user experience for a specific, critical measurement. While AI-CVD focuses on opportunistic screening, there is no explicit mention of its speed or ease of use in comparison to Rapid RV/LV's stated benefits for urgent PE assessment.
Clinical Value
AI-CVDAI-CVD offers a broader range of quantitative imaging measurements for cardiovascular and multisystem diseases, including CAC scoring, aortic and mitral valve analysis, and cardiac chamber volumetry, enabling early detection of hidden health risks. Rapid RV/LV, while crucial for pulmonary embolism severity assessment, focuses on a single, albeit important, metric (RV/LV ratio). AI-CVD's comprehensive approach suggests greater clinical value for general cardiovascular risk stratification.
Pricing & Value
TieNeither tool provides transparent pricing information in the given data. AI-CVD offers a free trial, which could be seen as an added value, but without pricing for either, a direct comparison of overall value is not possible. RapidAI states to contact the vendor for pricing information.
Enterprise Readiness
Rapid RV/LVRapidAI, the company behind Rapid RV/LV, boasts over 2,500 customers and a broader platform (Rapid PE solution) that includes triage, notification, and mobile app capabilities, indicating a more established and integrated enterprise solution. AI-CVD, while FDA-cleared and HIPAA compliant, does not provide comparable metrics for customer base or platform integration.
Innovation
AI-CVDAI-CVD focuses on opportunistic screening for a wide array of cardiovascular and multisystem diseases using existing CT scans, without requiring additional imaging or workflow disruption. This broad, proactive screening approach across multiple conditions represents a more innovative application of AI in early disease detection compared to Rapid RV/LV's more focused, albeit critical, application for PE severity.
Support & Docs
TieBoth tools are FDA-cleared and HIPAA compliant, implying a level of regulatory and data handling maturity. However, specific details regarding customer support, training, or documentation for either product are not provided in the given information, making it impossible to determine a winner in this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | AI-CVD | Rapid RV/LV |
|---|---|---|
| Name | AI-CVD | Rapid RV/LV |
| Company | HeartLung Corporation | RapidAI (formerly iSchemaView) |
| Key Functionality | Opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. | Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. |
| Core Measurements/Analysis | Coronary Artery Calcium (CAC) scoring, Aortic wall, aortic valve, and mitral valve calcium analysis, Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle), Epicardial fat volumetry, Aorta and pulmonary artery sizing | Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio |
| Categories | Cardiology AI | Cardiology AI, Radiology & Imaging AI |
Videos
Demos, reviews, and walkthroughs featuring AI-CVD and Rapid RV/LV.